Biofrontera Inc. (BFRIW) dividend history

BFRIWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BFRI

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 10/30

$0.00+0.00 (0.00%)

Close on Oct 30, 2026Market cap $12.96MP/E –Yield –

Dividends

Biofrontera has not reported a dividend

No dividend per share appears in Biofrontera's annual filings since fiscal 2019.

Where these numbers come from

Parsed from the XBRL in Biofrontera's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-20 reverse split on Jul 5, 2023
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is BFRIW.

Compare: BFRIW vs VRCA · BFRIW vs FBIO · BFRIW vs DERM · BFRIW vs OCUL · BFRIW vs SIGA

Revenue growth17.8% · median 15.5%

Operating margin-14.2% · median -42.9%

Net margin-13.8% · median -9.0%

Company	Revenue	Growth
FBIO	$68.47M	+15.5%
DERM	$68.18M	+20.9%
SIGA	$53.66M	-70.1%
OCUL	$52.05M	-8.1%
BFRIW	$46.18M	+17.8%
VRCA	$30.32M	+106.2%

Company

Next earnings (est.): Nov 12, 2026, before open
Exchange: Nasdaq
Industry: Pharmaceutical Preparations
Fiscal year ends: December 31
Employees: 92
Auditor: Marcum llp
SEC CIK: 1858685

Advertisement
300 × 250